Mankind Pharma IPO
GMP, Subscription, Price, Dates & Financial Details
Pharmaceutical & Drugs
Incorporated in 1991,Mankind Pharma Limited specializes in the manufacturing and marketing of pharmaceutical formulations for both acute and chronic therapeutic areas, along with consumer healthcare products. The company is primarily oriented towards the domestic market, which accounted for 97.6%…
Open Date
Tue, 25 Apr 2023
Close Date
Thu, 27 Apr 2023
Price Band
₹ 1026 – 1080
Lot Size
13
Issue Size
₹ 4,326.36 Cr
Minimum Investment
₹ 14,040 (13 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Mankind Pharma IPO has successfully completed its IPO process and is now listed on the NSE and BSE. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹4,326 Crore and an offer for sale (OFS) of 4.01 Crore equity shares aggregating to ₹4,326.36 Crore by the existing shareholders.
The Mankind Pharma IPO remained open for subscription from April 25, 2023, to April 27, 2023. The basis of allotment was finalized on May 03, 2023, and the company's shares were listed on the NSE and BSE on May 09, 2023.
The company had fixed the price band at ₹1026 to ₹1080 per share, with a lot size of 13 shares. Retail investors were required to make a minimum investment of ₹14,040 (based on the upper price band) to apply for one lot.
KFin Technologies Limited served as the registrar to the issue. IIFL Capital Services Limited, Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies India Private Limited acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Mankind Pharma Limited is now a publicly listed company on the NSE and BSE. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Mankind Pharma IPO Timeline (Tentative)
- IPO Open Date
- Tue, 25 Apr 23
- IPO Close Date
- Thu, 27 Apr 23
- Basis of Allotment
- Wed, 03 May 23
- Initiation of Refunds
- Thu, 04 May 23
- Credit of Shares to Demat
- Fri, 05 May 23
- Listing Date
- Tue, 09 May 23 — NSE & BSE
Open Date
25 April 2023
Close Date
27 April 2023
Basis Of Allotment
03 May 2023
Listing Date
09 May 2023
IPO Subscription
Check Live Subscription →The Mankind Pharma IPO has received bids for 42,95,12,902 shares against 2,80,41,192 shares offered, resulting in an overall subscription of 15.32x. the NII category is subscribed 3.8x, Retail Investors 0.92x, and QIBs 49.16x.
QIB
49.16x
NII
3.8x
RII
0.92x
Total
15.32x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 1,40,20,596 shares, representing 35% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 80,11,769 shares (20%), while Non-Institutional Investors (NIIs) receive 60,08,827 shares (15%).
| Category | Shares Offered | Shares Offered |
|---|---|---|
| Anchor Investors | 12,017,652 | 30% |
| Qualified Institutions | 8,011,769 | 20% |
| Non-Institutional | 6,008,827 | 15% |
| BNII | 4,005,885 | 10% |
| SNII | 2,002,942 | 5% |
| Retail Investors | 14,020,596 | 35% |
| Total | 40,058,844 | 100% |
Financials Details(₹ in Crores)
| Particular | 31-Mar-20 | 31-Mar-21 | 31-Dec-21 | 31-Mar-22 | 31-Dec-22 |
|---|---|---|---|---|---|
| Assets | 5073.29 | 6372.63 | 8043.88 | 9147.74 | 9273.75 |
| Revenue | 5975.65 | 6385.38 | 6218.29 | 7977.58 | 6777.82 |
| Profit After Tax | 1056.15 | 1293.03 | 1260.24 | 1452.96 | 1015.98 |
| Net Worth | 3485.31 | 4722 | 5965.46 | 6155.23 | 7145.89 |
| Reserve & Surplus | 3436.34 | 4674.39 | 5916.86 | 6106.06 | 7094.12 |
| Total Borrowings | 126.92 | 234.53 | 268.7 | 868.03 | 167.93 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Mankind Pharma Limited KPI Information
| Particular | The market capitalization of Mankind Pharma IPO is Rs 43263.6 Cr. |
|---|---|
| ROE % | 27.6 |
| ROCE % | 26.1 |
| RoNW % | 27.7 |
Peers Comparison
No Peer Comparision Available
About Mankind Pharma Limited
Incorporated in 1991,Mankind Pharma Limited specializes in the manufacturing and marketing of pharmaceutical formulations for both acute and chronic therapeutic areas, along with consumer healthcare products. The company is primarily oriented towards the domestic market, which accounted for 97.6% of its total revenue for the financial year 2022. It ranks as the fourth-largest pharmaceutical company in India based on domestic sales.
With a comprehensive marketing presence across India, Mankind Pharma operates 25 manufacturing facilities nationwide and boasts one of the largest distribution networks of medical representatives in the Indian pharmaceutical industry.
Mankind Pharma IPO Promoters
Mankind Pharma Limited Promoters
- Ramesh Juneja
- Rajeev Juneja
- Sheetal Arora
- Ramesh Juneja Family Trust
- Rajeev Juneja Family Trust
- Prem Sheetal Family Trust
Promoters Holding
Holding Pre Issue
79.00%
Holding Post Issue
76.50%
Mankind Pharma IPO Objective
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Carry out the Offer for Sale of 40,058,844Equity Shares by the Selling Shareholders aggregating to ₹43,263.55 million
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges. For further details
Mankind Pharma Limited Address / Contact Details
Mankind Pharma Limited
208, Okhla Industrial Estate,
Phase-III, New Delhi 110 020
Phone : +91 11 4747 6600
Email : investors@mankindpharma.com
Website : www.mankindpharma.com
IPO Snapshot
Mankind Pharma IPO Lot Size
The Mankind Pharma IPO has a lot size of 13 shares. Retail investors require a minimum investment of ₹14,040 by applying for 1 lot (13 shares). The maximum application allowed for the retail category is 14 lots (182 shares), requiring an investment of ₹1,96,560.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 13 | 14,040.00 |
| Retail (Max) | 14 | 182 | 196,560.00 |
| S-HNI (Min) | 15 | 195 | 210,600.00 |
| S-HNI (Max) | 71 | 923 | 996,840.00 |
| B-HNI (Min) | 72 | 936 | 1,010,880.00 |
Issue Reservation
- Anchor Investors — 30%
- QIB — 20%
- NII — 15%
- RII — 35%
Book Running Lead Managers
- IIFL Capital Services Limited
- Axis Capital Limited
- J.P. Morgan India Private Limited
- Jefferies India Private Limited
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Mankind Pharma IPO?
Mankind Pharma IPO is a Book-building IPO with a total issue size of ₹4326.36 crore. The Mankind Pharma IPO price band is ₹1026 to 1080 per share. The Mankind Pharma IPO subscription opens on Tue, Apr 25, 2023, and closes on Thu, Apr 27, 2023. The Mankind Pharma IPO will be listed on the NSE,BSE. KFin Technologies Limited is the registrar for the Mankind Pharma IPO.
When will the Mankind Pharma IPO open for subscription?
The Mankind Pharma IPO opens on Tue, Apr 25, 2023 and closes on Thu, Apr 27, 2023
What is Mankind Pharma IPO Price Band?
Mankind Pharma IPO Price Band is ₹1026 to 1080 per share.
What is Mankind Pharma IPO Lot Size?
Mankind Pharma IPO lot size is 13 shares, Retail investors need a minimum investment of ₹14040 based on the upper price band
What is the minimum investment for Mankind Pharma IPO?
The minimum investment for Mankind Pharma IPO is ₹14040, based on one lot of 13 shares at the upper price band of ₹1080 per share.
How to apply for Mankind Pharma IPO?
Investors can apply for the Mankind Pharma IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Thu, Apr 27, 2023. The application amount remains blocked until the Mankind Pharma IPO allotment is finalized.
What is Mankind Pharma IPO Issue Size?
Mankind Pharma IPO issue size is ₹4326.36 crores.
What is the Mankind Pharma IPO Allotment Date?
Mankind Pharma IPO allotment date is Wed, May 3, 2023.
Who is the Mankind Pharma IPO Registrar?
The registrar for Mankind Pharma IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited website to check Mankind Pharma IPO allotment status, refund processing, and other IPO-related information.
What is the Mankind Pharma IPO GMP?
The Mankind Pharma IPO GMP (Grey Market Premium) is ₹121 as of Tue, May 9, 2023. Based on the upper price band of ₹1080 per share, the estimated Mankind Pharma IPO listing price is ₹1201, indicating a potential listing gain of approximately 11.20% over the issue price.
Who is the Mankind Pharma IPO Lead Manager?
The book-running lead managers (BRLMs) for the Mankind Pharma IPO are Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies India Private Limited. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Mankind Pharma IPO Red Herring Prospectus (RHP).